MedTrace Logo

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

NCT02393937 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 963

Last updated 2020-09-03

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of two Metronidazole Gels 1%, in the treatment of Rosacea.

Conditions

  • Papulopustular Rosacea
  • Erythematotelangiectatic Rosacea

Interventions

DRUG

Reference: Metronidazole Gel 1%

Participants are assigned to one of three groups in parallel for the duration of the study

DRUG

Test: Metronidazole Gel 1%

Participants are assigned to one of three groups in parallel for the duration of the study

DRUG

Placebo Gel

Participants are assigned to one of three groups in parallel for the duration of the study

Sponsors & Collaborators

  • bioRASI, LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-07-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02393937 on ClinicalTrials.gov